Cargando…
NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines
The RET fusion is considered as the potential novel target in solid tumors. However, RET fusion is not well yet identified in colorectal cancer (CRC), and the effect of RET kinase inhibitor is also not evaluated in CRC with RET fusion. We established patient-derived tumor cells (PDCs) with RET fusio...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134812/ https://www.ncbi.nlm.nih.gov/pubmed/30210625 http://dx.doi.org/10.7150/jca.26256 |